Literature DB >> 4640945

Effect of rheumatoid factor on complement-mediated phagocytosis.

F C McDuffie, H W Brumfield.   

Abstract

The frequency and amount of IgM rheumatoid factor (RF) in the blood of patients with rheumatoid arthritis (RA) correlate with the severity of the disease and the number of complications. Though previous studies of RF in subacute bacterial endocarditis have shown that RF inhibits phagocytosis of microorganisms by granulocytes, the presence of low levels of complement (C) in blood and synovial fluid of patients with the highest titers of RF suggests that an interaction between RF and C may contribute to the inflammatory process in RA. We thus employed a quantitative methodology to examine the effect of RF on complement-dependent phagocytosis of sheep erythrocytes by rabbit granulocytes. Addition of 2500 molecules of IgM RF to sheep cells heavily coated with IgG antibody (195,000 molecules per cell) resulted in virtually complete inhibition of uptake of C3 (beta(1c)) and prevention of phagocytosis, an effect resulting from inhibition of uptake of C1 by the cells. When erythrocytes coated with only 34,000 molecules of IgG antibody were employed, phagocytosis was similarly inhibited. However the effect of RF on such cells was shown to be primarily mediated through inhibition of C4 rather than C1 uptake. Although the results do not exclude the participation of an IgM RF of higher avidity, present only in the tissues in rheumatoid inflammation, circulating IgM RF probably does not play a potentiating role in rheumatoid inflammation.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4640945      PMCID: PMC332983          DOI: 10.1172/JCI107128

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Antibody-complement complexes.

Authors:  W F Willoughby; M M Mayer
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

3.  Agglutinating activity of the complement component C'1q in the F-II latex fixation test.

Authors:  R W Ewald; A F Schubart
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

4.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

5.  Properties of antibodies cytophilic for macrophages.

Authors:  A Berken; B Benacerraf
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

6.  IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity.

Authors:  K Onoue; N Tanigaki; Y Yagi; D Pressman
Journal:  Proc Soc Exp Biol Med       Date:  1965-11

7.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

8.  Number of molecules of antibody required to promote phagocytosis of one bacterium.

Authors:  D Rowley; K J Turner
Journal:  Nature       Date:  1966-04-30       Impact factor: 49.962

9.  Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

Authors:  H J Müller-Eberhard; M J Polley; M A Calcott
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307

View more
  7 in total

1.  Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG.

Authors:  R D Rossen; M A Reisberg; J T Sharp; W N Sucki; F X Schloeder; L L Hill; G Eknoyan
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

Review 2.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

3.  Rheumatoid factor and monosodium urate crystal-neutrophil interactions in gouty inflammation.

Authors:  R A Turner; G B Counts; W J Treadway; D A Holt; C A Agudelo
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

4.  Complement fixation by rheumatoid factor.

Authors:  K Tanimoto; N R Cooper; J S Johnson; J H Vaughan
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

5.  Rheumatoid factor and tumor-host interaction.

Authors:  J J Twomey; R D Rossen; V M Lewis; A H Laughter; C C Douglass
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

6.  Neutrophil enzyme activities in rheumatoid inflammation.

Authors:  R Turner; M Martin; J Schroff; W Treadway; L DeChatelet
Journal:  Inflammation       Date:  1979-07       Impact factor: 4.092

7.  Complement activation induced by rabbit rheumatoid factor.

Authors:  R R Meyer; J C Brown
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.